liver-mets

Skip to content The CRC Digest Blood-Based ctDNA Testing May Help Monitor for Cancer Return After Surgery Meta-analysis supports use of circulating tumor DNA as a biomarker to detect recurrence risk in patients who had liver metastases surgically removed. (Clinical Colorectal Cancer) This content is informational only and does not